Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Janz, Martin Dr. (6) Kammertöns, Thomas Dr. (3) Kirchner, Marieluise Dr. (2) Landthaler, Markus Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Pombo, Ana Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (6) Uckert, Wolfgang Prof. Dr. (1) Wollert-Wulf, Brigitte (2) Wyler, Emanuel Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (7) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) (-) Molekulare Immunologie und Gentherapie (7) Tumorgenetik und zelluläre Stressantworten (1) 1992 (4) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2011 (5) (-) 2012 (6) 2013 (11) 2014 (4) 2015 (3) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2020 (1) 2021 (6) 2022 (6) 2023 (6) 2024 (1) 7 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Molekulare Immunologie und Gentherapie 20062012 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. April 2012 / Nat Rev Cancer The determinants of tumour immunogenicity T. Blankenstein P.G. Coulie E. Gilboa E.M. Jaffee 30. März 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm 01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens 01. Oktober 2012 / Transgenic Res Depot formation of doxycycline impairs Tet-regulated gene expression in vivo K. Anders C. Buschow J. Charo T. Blankenstein 01. Oktober 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein 01. November 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. April 2012 / Nat Rev Cancer The determinants of tumour immunogenicity T. Blankenstein P.G. Coulie E. Gilboa E.M. Jaffee
30. März 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm
01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens
01. Oktober 2012 / Transgenic Res Depot formation of doxycycline impairs Tet-regulated gene expression in vivo K. Anders C. Buschow J. Charo T. Blankenstein
01. Oktober 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein
01. November 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein